191 related articles for article (PubMed ID: 25137041)
21. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
[TBL] [Abstract][Full Text] [Related]
22. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
Czarnecka KH; Migdalska-Sęk M; Domańska D; Pastuszak-Lewandoska D; Dutkowska A; Kordiak J; Nawrot E; Kiszałkiewicz J; Antczak A; Brzeziańska-Lasota E
Int J Oncol; 2016 Sep; 49(3):1175-84. PubMed ID: 27572663
[TBL] [Abstract][Full Text] [Related]
23. AEG-1 mRNA expression in non-small cell lung cancer is associated with increased tumor angiogenesis.
Ma Z; Chen Y; Dong S; Xu X; Liu J; Song P; Yu C; Dai L
Pathol Res Pract; 2017 Oct; 213(10):1257-1263. PubMed ID: 28941723
[TBL] [Abstract][Full Text] [Related]
24. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
25. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.
Tang JZ; Zuo ZH; Kong XJ; Steiner M; Yin Z; Perry JK; Zhu T; Liu DX; Lobie PE
Endocrinology; 2010 Jan; 151(1):43-55. PubMed ID: 19966185
[TBL] [Abstract][Full Text] [Related]
26. Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a.
Yip SH; Eguchi R; Grattan DR; Bunn SJ
J Neuroendocrinol; 2012 Dec; 24(12):1484-91. PubMed ID: 22775396
[TBL] [Abstract][Full Text] [Related]
27. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
[TBL] [Abstract][Full Text] [Related]
28. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
[TBL] [Abstract][Full Text] [Related]
29. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the relationship between the IL-17A gene expression level and regulatory miRNA-9 in relation to tumor progression in patients with non-small cell lung cancer: a pilot study.
Migdalska-Sęk M; Góralska K; Jabłoński S; Kordiak J; Nawrot E; Kiszałkiewicz JM; Pastuszak-Lewandoska D; Baran K; Stuss M; Brzeziańska-Lasota E
Mol Biol Rep; 2020 Jan; 47(1):583-592. PubMed ID: 31707599
[TBL] [Abstract][Full Text] [Related]
31. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
Wang WB; Cui YG; Yao SY
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
[TBL] [Abstract][Full Text] [Related]
32. [Expression and clinical significance of mTOR and PTEN in non-small cell lung cancer].
Wang L; Xu S; Yue W; Zhao X; Zhang L; Wang Y
Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):717-21. PubMed ID: 20673489
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
34. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.
Lee TK; Man K; Poon RT; Lo CM; Yuen AP; Ng IO; Ng KT; Leonard W; Fan ST
Cancer Res; 2006 Oct; 66(20):9948-56. PubMed ID: 17047057
[TBL] [Abstract][Full Text] [Related]
35. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
36. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
[TBL] [Abstract][Full Text] [Related]
37. Analysis of MAT3 gene expression in NSCLC.
Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G
Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548
[TBL] [Abstract][Full Text] [Related]
38.
Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
[TBL] [Abstract][Full Text] [Related]
39. BCR-ABL affects STAT5A and STAT5B differentially.
Schaller-Schönitz M; Barzan D; Williamson AJ; Griffiths JR; Dallmann I; Battmer K; Ganser A; Whetton AD; Scherr M; Eder M
PLoS One; 2014; 9(5):e97243. PubMed ID: 24836440
[TBL] [Abstract][Full Text] [Related]
40. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
